Tempus AI, Inc.

Tempus AI, Inc. has 2 AI-enabled medical devices on the FDA list. The first decision was on June 21, 2024 and the most recent on July 15, 2025 (Tempus ECG-Low EF). Its most common review panel is Cardiovascular (2 devices).